Publications
223
Citations
2,578
Est. group size
~52
Recurring co-author estimate
Active years
22
Publishing since 2005
Sumithira Vasu's research centers on blood and bone marrow transplantation, particularly complications like graft-versus-host disease and transplant-associated thrombotic microangiopathy (a blood vessel injury that can occur after transplant). Work also covers treatments for acute leukemias and rare blood cancers such as blastic plasmacytoid dendritic cell neoplasm, including drug therapies and cell-based treatments. Much of this research involves multi-institutional clinical trials and consensus guideline development conducted with large transplant research consortia.
Publication output rose sharply from 2017 through 2021 and has since leveled off, remaining fairly steady at around 23-26 papers per year through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- AML-1310: Subgroup Analysis by Fitness Criteria of Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With First-Line Tagraxofusp
Clinical Lymphoma Myeloma & Leukemia · 2025
- POSTER: AML-1310 Subgroup Analysis by Fitness Criteria of Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With First-Line Tagraxofusp
Clinical Lymphoma Myeloma & Leukemia · 2025
- Subgroup analysis by fitness criteria of patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with first-line (1L) tagraxofusp (TAG).
Journal of Clinical Oncology · 2025
- Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
Blood · 2025
- An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy
Transplantation and Cellular Therapy · 2025
- First‐line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial
British Journal of Haematology · 2025
- Outcomes and Clinical Characteristics of Adult Patients with Transplant Associated Thrombotic Microangiopathy: A Single Center Experience
Blood · 2024
- Early Complications of Endothelial Origin
2024
- POSTER: AML-303 Tagraxofusp, an Anti-CD123 Therapy, in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm and Prior or Concomitant Hematologic Malignancies: Subgroup Analysis of a Pivotal Trial
Clinical Lymphoma Myeloma & Leukemia · 2023
- AML-303 Tagraxofusp, an Anti-CD123 Therapy, in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm and Prior or Concomitant Hematologic Malignancies: Subgroup Analysis of a Pivotal Trial
Clinical Lymphoma Myeloma & Leukemia · 2023
- Development of IoT Based Pneumatic Punching Machine
Journal of Mines Metals and Fuels · 2023
- Modelling and Analysis of The Effect of Plateau Honing Operation on Cylinder Liners
Journal of Mines Metals and Fuels · 2023
- Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report from the BMT CTN Patient and Caregiver Advocacy Task Force
Transplantation and Cellular Therapy · 2023
- An analysis of a first-in-human study of NEXI-001 donor-derived antigen-specific CD8+ T-cell treatment of relapsed AML after allogeneic hematopoietic cell transplantation (HCT).
Journal of Clinical Oncology · 2023
- Cellular therapies: Hematology and beyond
Seminars in Hematology · 2023
- Blood×55
- Transplantation and Cellular Therapy×41
- Biology of Blood and Marrow Transplantation×17
- Journal of Clinical Oncology×14
- Clinical Lymphoma Myeloma & Leukemia×14
- Julianna Roddy
Medicine · The Ohio State University
- Brandon M. Triplett
Medicine · Purdue University West Lafayette
- Hannah Choe
Medicine · The Ohio State University
- Marcos de Lima
Medicine · The Ohio State University
- Ayman Saad
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile